🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
Chimeric antigen receptor T cells (car-t) is one of the most effective ther...
Status
Completed
Location
No.3, Qingchun East Road
Start Date
2018-10-11
Trial ID
NCT04650724
Treatments Being Tested
This study is a single-center, open-label, dose-exploration trial designed ...
Status
Not Yet Recruiting
Location
Multiple Locations
Start Date
2026-02-15
Trial ID
NCT07185490
Treatments Being Tested
The goal of this clinical trial is to test the safety and potential benefit...
Status
Recruiting
Location
Department of Rheumatology and Immunology, the First Medical Center, Chinese PLA General Hospital
Start Date
2025-09-05
Trial ID
NCT07148791
Treatments Being Tested
This is an interventional, modular, open-label, multicenter study to primar...
Status
Recruiting
Location
Research Site
Start Date
2025-07-31
Trial ID
NCT07073547
Treatments Being Tested
This trial is a Phase 1b/2, open-label, multicenter study of AZD0120, a CD1...
Status
Recruiting
Location
Research Site
Start Date
2023-07-20
Trial ID
NCT05850234
Treatments Being Tested
This study is a single-arm, open-lable, phase I/II study to evaluate the ef...
Status
Recruiting
Location
Research Site
Start Date
2023-12-26
Trial ID
NCT06235229
Treatments Being Tested
This is an open-label, multicenter, Phase 1/2 study to determine the safety...
Status
Completed
Location
Local Institution - 0006
Start Date
2018-02-01
Trial ID
NCT03430011
Treatments Being Tested
This is a phase I/II, single-arm, open-lable study of autologous stem cell ...
Status
Recruiting
Location
Institute of Hematology & Blood Diseases Hospital
Start Date
2022-07-14
Trial ID
NCT05632380
Treatments Being Tested
This trial is a Phase 1b, open-label, multi-center, clinical study of AZD01...
Status
Recruiting
Location
Research Site
Start Date
2026-01-09
Trial ID
NCT07295847
Treatments Being Tested
It is a dose expansion, open-label, phase Ib study to evaluate the safety, ...
Status
Unknown
Location
The University of Texas MD Anderson Cancer Center
Start Date
2023-05-08
Trial ID
NCT05698303
Treatments Being Tested